0001104659-26-026146
SEC filingSagimet Biosciences Inc. furnished Item 2.02 results of operations, Item 7.01 investor presentation, and Exhibits 99.1 press release and 99.2 investor presentation dated March 11, 2026. Item 2.02 and Item 7.01 are not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934.